Clinical Trial: The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery
Brief Summary:
PKAZ is a single institution study designed to evaluate the optimal dosing parameters for azithromycin for pre-surgical cesarean prophylaxis.
Hypothesis: Pre-operative administration of azithromycin results in maternal and neonatal tissue concentrations that adequately treat microbes commonly involved in post-cesarean infections.
Detailed Summary:
Sponsor: University of Alabama at Birmingham
Current Primary Outcome: Number of Patients in Each Group That Attain an Adequate Azithromycin Concentration [ Time Frame: 48 hours after delivery ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University of Alabama at Birmingham
Dates:
Date Received: October 26, 2011
Date Started: November 2011
Date Completion:
Last Updated: April 4, 2017
Last Verified: April 2017